Skip to main content

Table 2 Body weight and height, lipid profile and hematological parameters were measured on the day of tissue harvesting (18 weeks) of INO-1001 treated mice and controls.

From: PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels

Parameter

INO-1001-treated

(n = 15) ± S.D.

Control (n = 15) ± S.D.

P value

Leukocytes [/nl]

1.80 ± 0.96

1.73 ± 0.98

n.s.

Erythrocytes [/pl]

7.76 ± 1.27

7.25 ± 1.68

n.s.

Hemoglobin [g/dl]

12.16 ± 0.94

11.75 ± 2.41

n.s.

Thrombocytes [/nl]

797.38 ± 308.17

587.33 ± 504.32

n.s.

Triglycerides [mg/dl]

66.43 ± 21.00

62.75 ± 32.13

n.s.

Total Cholesterol [mg/dl]

839.82 ± 160.22

834.00 ± 155.09

n.s.

LDL Cholesterol [mg/dl]

812.68 ± 158.38

806.00 ± 152.00

n.s.

HDL Cholesterol [mg/dl]

13.93 ± 5.08

17.10 ± 10.49

n.s.

Body weight [g]

30.60 ± 3.10

31.27 ± 2.80

n.s.

Height [cm]

10.10 ± 1.32

10.75 ± 1.63

n.s.

  1. All values are shown as mean ± S.D.. n.s. = not significant.